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Matters Arising
ªvariantº isoform of RHAMM (Figure 1) that causedProblems with RHAMM: A New
transformation and metastasis formation when overex-
Link between Surface Adhesion pressed in immortalized murine fibroblasts (Hall et al.,
1995).and Oncogenesis?
Based on the published cDNA sequence, we raised
three polyclonal antibodies recognizing different epi-In a quite spectacular report, a novel mechanism of cell
topes in human and murine RHAMM proteins, each oftransformation was proposed: a matrix receptor linked
which only recognizes either an 85 kDa protein in ex-by a GPI anchor to the outer surface of the plasma
tracts of human cells (Assmann et al., 1998) or a singlemembrane, called RHAMM (receptor for hyaluronic acid
95 kDa protein in extracts of immortalized murine cellsmediated motility), acted as a dominant oncogene and
and primary tissues (Hofmann et al., 1998; Fieber et al.,was required for transformation (Hall et al., 1995). This
1998; see Figure 1). We also isolated additional se-finding stimulated subsequent investigations that have
quences at the 59 end of the murine RHAMM cDNArevealed significant inconsistencies with the original
(Hofmann et al., 1998) that share high homology withstudy and with several other. The aim of this letter is to
the 59 end of the newly isolated human RHAMM cDNAclarify these discrepancies and to stimulate discussion
clones (Wang et al., 1996; Assmann et al., 1998). Theon this controversial issue.
new 59 sequences are encoded by additional exons thatRHAMM was originally identified as a 56±58 kDa hyal-
are contiguous with ªRHAMMº genomic sequencesuronate-binding protein present in the supernatant of
(Fieber et al., 1998; see Figure 1). Ectopic expression ofmurine fibroblasts and fibrosarcoma cell lines (Turley
our full-length murine cDNA in human fibroblasts leadset al., 1987). A polyclonal antibody raised against this
to the expression of the 95 kDa protein only (Hofmannprotein stained structures on the cell surface (Turley et
et al., 1998). In RHAMM null mice the 95 kDa proteinal., 1990; Hardwick et al., 1992; Samuel et al., 1993). A
exclusively disappears (unpublished data). Finally, ex-
first cDNA sequence for murine RHAMM, which con-
tensive RT-PCR analyses of various tissues fail to detect
tained an open reading frame encoding a 52 kDa poly- alternatively spliced RNAs or variation in the expression
peptide, was isolated using this polyclonal antibody of the v4 exon (exon 8). Taken as a whole, these data
(Hardwick et al., 1992; see Figure 1). However, subse- argue against major splicing-based variation in RHAMM
quent studies using antibodies based upon this cDNA gene products. Moreover, they suggest that the RHAMM
clone sequence information have recognized numerous cDNA clone used in the above transformation experi-
apparent RHAMM protein isoforms ranging from 52 to ments (Hall et al., 1995) encodes an N-terminally trun-
125 kDa (e.g., Hardwick et al., 1992; Entwistle et al., cated nonnative ªRHAMMº protein.
1995; Hall et al., 1996). Molecular masses of 58, 60, Structural predictions from the full-length cDNA se-
64, 70, and 84 kDa have been reported for the human quences of both human and murine ªRHAMMº revealed
RHAMM protein (see citations in Hofmann et al., 1998). no sequences predisposing the protein to be trans-
Later it became apparent that the cDNA described by ported to the plasma membrane. Consistent with this,
Hardwick et al. (1992) was not full length. A subsequent we found only intracellular, mostly cytoplasmic dis-
RHAMM cDNA clone isolate (Entwistle et al., 1995; see tribution of RHAMM in all cell types examined, while
Figure 1) thought to be full-length murine RHAMM cDNA, neither surface staining nor protein shedding could be
contained an ORF encoding a polypeptide of 70 kDa. A detected (Assmann et al., 1998; Hofmann et al., 1998).
putative splice variant of this cDNA clone contained an In contrast, Hall et al. (1995) reported that overexpres-
sion of RHAMM1v4 in immortalized murine fibroblastsadditional exon, named ªv4,º and encoded a 72 kDa
Figure 1. Comparison of Murine RHAMM
Open Reading Frames from cDNA Isolates
and the Genomic Structure
The filled box in exon 4 of Entwistle et al.
(1995) corresponds to exon 8 of Fieber et al.
(1998) and is the so-called v4 exon. Part of
exon 2 (Entwistle) corresponds to exon 6
(Fieber), but the portion of exon 2 (Entwistle)
shown as a horizontally striped box repre-
sents intronic sequences in Fieber et al., 1998
(also see Hofmann et al., 1998). The striped
box in exon 1 (Entwistle) matches part of exon
5 (Fieber). The ªrepeat regionº is indicated by
the densely hatched boxes in exon 8 (Entwis-
tle) and exon 12 (Fieber), and the hyaluronate-
binding sites are indicated by the sparsely
hatched boxes in exons 12 and 13 (Entwistle)
and exons 16 and 17 (Fieber). The complete
open reading frame is also called IHABP (Hof-
mann et al., 1998).
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resulted in a 20-fold increase of RHAMM on the cell Response to Hofmann et al.
surface (see Table 1 of Hall et al., 1995). Curiously, the
same RHAMM1v4 isoform expressed in the same cells
RHAMM belongs to a group of hyaladherins that regu-was later reported to be located exclusively in the cyto-
late cell motility and cell cycle and that are expressedplasm (Zhang et al., 1998).
in the cytoplasm, nucleus, and cell surface, in spite ofQuestions about the physiological significance of the
a lack of signal peptide or transmembrane domain. Com-RHAMM transformation data are raised by the fact that
plexity of RHAMM distribution and transient expressionthe link between surface hyaluronan binding and trans-
of its small isoforms lies at the heart of the currentformation has become doubtful and that the transforma-
controversy. We first reported the full-length long formtion studies used a truncated and incompletely pro-
of the human RHAMM cDNA (Wang et al., 1996). Thiscessed RHAMM cDNA clone. The same is true of other
cDNA was later recloned by Assmann et al. (1998). Hof-work using these truncated murine RHAMM constructs
mann et al. (1998) obtained the murine homolog. A(e.g., Zhang et al., 1998). Nonetheless the role of this
smaller RHAMM isoform (v4; Hall et al., 1995) was vari-protein in transformation still warrants further investiga-
ably detected in 3T3 cells with 59 RACE, primer exten-tion and could yet represent a novel pathway of onco-
sion, and RT-PCR and corresponded to a minor 70±73genic activity.
kDa protein (references in Zhang et al., 1998). This iso-
form is constitutively detected by RT-PCR in ras-trans-
formed cells, the 59 UTR is present in the RHAMM geneMartin Hofmann,*³ Volker Assmann,² Christina Fieber,*
(unpublished data), and this isoform is transformingJonathan P. Sleeman,* JuÈ rgen Moll,* Helmut Ponta,*
when overexpressed in 10T1/2 fibroblasts. Regrettably,Ian R. Hart,² and Peter Herrlich*
in our Cell manuscript, we did not report a compari-*Forschungszentrum Karlsruhe and
son between the transfected v4 and native v4 proteins.University of Karlsruhe
In RHAMMv4 transformed cells, surface RHAMM wasInstitutes of Genetics
elevated and we mistakenly predicted this surfaceD-76021 Karlsruhe, Germany
population to be v4 (Hall et al., 1995). Subsequent epi-²Richard Dimbleby Department of Cancer Research
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groups have been unable to find a v4 isoform, they and
we noted the presence of multiple RNA transcripts and
proteins, the latter even in transfected cells (HofmannReferences
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